Nivalis Therapeutics Quick Ratio 2013-2020 | ALPN

Historical quick ratio values for Nivalis Therapeutics (ALPN) over the last 10 years.
Nivalis Therapeutics Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2020-06-30 $0.00B $0.03B 0.00
2020-03-31 $0.00B $0.01B 0.00
2019-12-31 $0.00B $0.01B 0.00
2019-09-30 $0.00B $0.01B 0.00
2019-06-30 $0.00B $0.01B 0.00
2019-03-31 $0.00B $0.01B 0.00
2018-12-31 $0.00B $0.01B 0.00
2018-09-30 $0.00B $0.01B 0.00
2018-06-30 $0.00B $0.00B 0.00
2018-03-31 $0.00B $0.00B 0.00
2017-12-31 $0.00B $0.00B 0.00
2017-09-30 $0.00B $0.00B 0.00
2017-06-30 $0.00B $0.00B 0.00
2017-03-31 $0.00B $0.00B 0.00
2016-12-31 $0.00B $0.00B 0.00
2016-09-30 $0.00B $0.01B 0.00
2016-06-30 $0.00B $0.01B 0.00
2016-03-31 $0.00B $0.01B 0.00
2015-12-31 $0.00B $0.00B 0.00
2015-09-30 $0.00B $0.00B 0.00
2015-06-30 $0.00B $0.01B 0.00
2015-03-31 $0.00B $0.00B 0.00
2014-12-31 $0.00B $0.00B 0.00
2014-09-30 $0.00B 0.00
2014-06-30 $0.00B 0.00
2014-03-31 $0.00B 0.00
2013-12-31 $0.00B $0.00B 0.00
2012-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.188B $0.002B
Alpine Immune Sciences Inc. operates as a specialty pharmaceutical company. It engages in the discovery and development of protein-based immunotherapies for the treatment of cancer, inflammatory disorders and other diseases. Alpine Immune Sciences Inc., formerly known as Nivalis Therapeutics, is based in Seattle, Washington.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $76.741B 43.65
Takeda Pharmaceutical (TAK) Japan $58.610B 10.21
Astellas Pharma (ALPMY) Japan $28.578B 14.48
Eisai (ESALY) Japan $26.827B 22.67
UCB SA (UCBJF) Belgium $22.446B 0.00
Merck (MKGAF) Germany $18.966B 24.87
Ono Pharmaceutical (OPHLF) Japan $15.737B 27.83
Catalent (CTLT) United States $14.011B 45.54
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.140B 0.00
Grifols, S.A (GRFS) Spain $10.808B 13.21
Neurocrine Biosciences (NBIX) United States $9.319B 36.08
IPSEN SA ADR (IPSEY) France $9.086B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $8.360B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.720B 12.77
STADA ARZNEIMI (STDAF) Germany $7.169B 0.00
Ionis Pharmaceuticals (IONS) United States $7.092B 44.93
Orion OYJ (ORINY) Finland $7.077B 24.56
United Therapeutics (UTHR) United States $4.543B 10.50
Arrowhead Pharmaceuticals (ARWR) United States $4.480B 0.00
Evotec AG (EVTCY) Germany $4.014B 139.34
FibroGen (FGEN) United States $3.961B 0.00
ChemoCentryx (CCXI) United States $3.640B 0.00
Nektar Therapeutics (NKTR) United States $3.560B 0.00
Hypermarcas (HYPMY) Brazil $3.553B 13.07
Sage Therapeutics (SAGE) United States $3.215B 0.00
PTC Therapeutics (PTCT) United States $3.122B 0.00
Pacira BioSciences (PCRX) United States $2.586B 67.98
Xencor (XNCR) United States $2.224B 0.00
Revolution Medicines (RVMD) United States $2.191B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.141B 10.36
Corcept Therapeutics (CORT) United States $2.059B 18.96
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.871B 0.00
Cronos Group (CRON) Canada $1.858B 0.00
USANA Health Sciences (USNA) United States $1.604B 15.11
Ironwood Pharmaceuticals (IRWD) United States $1.549B 10.76
Heron Therapeutics (HRTX) United States $1.410B 0.00
Indivior (INVVY) United States $1.348B 16.71
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.304B 12.43
Trillium Therapeutics (TRIL) Canada $1.271B 0.00
Zogenix (ZGNX) United States $1.252B 0.00
Karyopharm Therapeutics (KPTI) United States $1.194B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.082B 0.00
Esperion Therapeutics (ESPR) United States $1.041B 0.00
CLINIGEN GP (CLIGF) United Kingdom $0.991B 0.00
Translate Bio (TBIO) United States $0.984B 0.00
VAXART, INC (VXRT) United States $0.956B 0.00
Vectura Group (VEGPF) United Kingdom $0.894B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.894B 556.75
Endo (ENDP) Ireland $0.722B 1.07
Tilray (TLRY) Canada $0.682B 0.00
ImmunoGen (IMGN) United States $0.674B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.672B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.666B 0.00
Collegium Pharmaceutical (COLL) United States $0.625B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.587B 0.00
Siga Technologies (SIGA) United States $0.567B 60.50
Aerie Pharmaceuticals (AERI) United States $0.563B 0.00
Radius Health (RDUS) United States $0.547B 0.00
Ocular Therapeutix (OCUL) United States $0.547B 0.00
Flexion Therapeutics (FLXN) United States $0.546B 0.00
Molecular Templates (MTEM) United States $0.528B 0.00
Ardelyx (ARDX) United States $0.505B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.476B 0.00
Altimmune (ALT) United States $0.472B 0.00
Harpoon Therapeutics (HARP) United States $0.431B 0.00
Organogenesis Holdings (ORGO) United States $0.401B 0.00
Akebia Therapeutics (AKBA) United States $0.400B 0.00
TherapeuticsMD (TXMD) United States $0.398B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.394B 19.67
Rigel Pharmaceuticals (RIGL) United States $0.383B 0.00
Redhill Biopharma (RDHL) Israel $0.369B 0.00
MEI Pharma (MEIP) United States $0.367B 0.00
DURECT (DRRX) United States $0.353B 0.00
PROFOUND MEDICL (PROF) Canada $0.343B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.338B 8.38
Innate Pharma SA (IPHYF) France $0.324B 0.00
IMV INC (IMV) Canada $0.321B 0.00
Xeris Pharmaceuticals (XERS) United States $0.304B 0.00
Jounce Therapeutics (JNCE) United States $0.297B 14.08
Concert Pharmaceuticals (CNCE) United States $0.296B 0.00
Aquestive Therapeutics (AQST) United States $0.285B 0.00
Menlo Therapeutics (VYNE) United States $0.285B 0.00
Rafael Holdings (RFL) United States $0.273B 0.00
Calithera Biosciences (CALA) United States $0.257B 0.00
Lannett Co Inc (LCI) United States $0.245B 5.68
KalVista Pharmaceuticals (KALV) United States $0.241B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.223B 0.00
Nature's Sunshine Products (NATR) United States $0.222B 21.92
Avadel Pharmaceuticals (AVDL) Ireland $0.219B 0.00
Heat Biologics (HTBX) United States $0.209B 0.00
Taiwan Liposome (TLC) Taiwan $0.193B 0.00
CASI Pharmaceuticals (CASI) United States $0.191B 0.00
OptiNose (OPTN) United States $0.188B 0.00
Otonomy (OTIC) United States $0.171B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.159B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.158B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.140B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.134B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.117B 0.00
Champions Oncology (CSBR) United States $0.113B 0.00
Aclaris Therapeutics (ACRS) United States $0.107B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.105B 0.00
Lipocine (LPCN) United States $0.102B 0.00
Hemispherx BioPharma (AIM) United States $0.101B 0.00
MediWound (MDWD) Israel $0.097B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.083B 0.00
Biomerica (BMRA) United States $0.081B 0.00
CTI BioPharma (CTIC) United States $0.081B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.079B 0.00
ElectroCore (ECOR) United States $0.079B 0.00
Novan (NOVN) United States $0.076B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.074B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.072B 0.00
Addex Therapeutics (ADXN) Switzerland $0.070B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.067B 0.00
Infinity Pharmaceuticals (INFI) United States $0.066B 0.00
Onconova Therapeutics (ONTX) United States $0.057B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.057B 0.00
Recro Pharma (REPH) United States $0.054B 0.00
CV Sciences (CVSI) United States $0.054B 0.00
SCYNEXIS (SCYX) United States $0.052B 0.00
KemPharm (KMPH) United States $0.050B 0.00
Natural Alternatives (NAII) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.050B 29.91
India Globalization Capital (IGC) United States $0.049B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.047B 0.00
GTx (ONCT) United States $0.042B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
IsoRay (ISR) United States $0.040B 0.00
PolarityTE (PTE) United States $0.040B 0.00
ProPhase Labs (PRPH) United States $0.039B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 8.93
AgeX Therapeutics (AGE) United States $0.033B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.029B 0.00
Can-Fite Biopharma (CANF) Israel $0.029B 0.00
Jaguar Animal Health (JAGX) United States $0.028B 0.00
Sundial Growers (SNDL) Canada $0.024B 0.00
Midatech Pharma (MTP) United Kingdom $0.023B 0.00
Vical (BBI) United States $0.023B 0.00
Regulus Therapeutics (RGLS) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.017B 0.00
HANCOCK JAFFE (HJLI) United States $0.017B 0.00
Flex Pharma (SLRX) United States $0.016B 0.00
Cyanotech (CYAN) United States $0.016B 24.09
Bio-Path Holdings (BPTH) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.012B 0.00
JanOne (JAN) United States $0.009B 0.00
China SXT Pharmaceuticals (SXTC) China $0.008B 0.00
Shineco (TYHT) China $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00